Thank you.
You all seem to be in agreement that our strategic technology decision to occupy the international market was correct. You all seem to say that we should ramp up the NRU and try to fill a void that would be in place for the reactivation of the MAPLEs. And you all seem to be in agreement that the technology and the resources, with some tuning of the statutory legislative regime, would produce some value-added results.
At the last meeting we were told by the people at McMaster University that when fully activated the McMaster system could fill four times the Canadian need for isotopes. Do you think the fourth part of the strategy should be to accelerate that option while we do the other things you've suggested? Is this a viable strategy, given that we want to continue to meet our international responsibilities but that we may have to make some temporary adjustments to satisfy Canadian medical needs?